iRadimed Financial Ratios
NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRadimed ratio analysis
iRadimed earned a net margin of 26.8% in FY 2025, up from 26.3% a year earlier. Gross margin was 76.7% compared with a median of 76.6% over the prior 9 years. Return on equity reached 23.8%, meaning iRadimed generated 0.24 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, IRMD traded at 54.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 18.5 to 378.8, with a median of 41.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
iRadimed financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 54.57 | 37.01 | 35.16 | 27.74 | 62.45 | 207.27 | 31.42 | 46.75 | 378.75 | 18.50 |
| Price / sales | 14.50 | 9.60 | 9.13 | 6.67 | 13.64 | 8.72 | 7.18 | 8.59 | 6.98 | 3.70 |
| Price / book | 12.84 | 8.10 | 8.38 | 4.82 | 7.90 | 4.50 | 4.98 | 6.24 | 4.89 | 3.77 |
| Gross margin | 76.7% | 76.9% | 76.5% | 77.4% | 76.6% | 74.3% | 77.1% | 76.3% | 75.9% | 81.1% |
| Operating margin | 31.2% | 30.0% | 30.6% | 29.3% | 23.5% | -2.4% | 22.5% | 19.7% | 5.6% | 33.6% |
| Net margin | 26.8% | 26.3% | 26.2% | 24.1% | 22.3% | 4.3% | 25.0% | 20.7% | 2.2% | 22.2% |
| Free cash flow margin | 20.5% | 24.1% | 9.2% | 17.3% | 25.8% | 16.9% | 25.6% | 23.5% | 11.4% | 26.5% |
| Return on equity (ROE) | 23.8% | 22.2% | 24.1% | 17.4% | 12.9% | 2.2% | 17.3% | 15.0% | 1.5% | 22.6% |
| Return on assets (ROA) | 20.7% | 19.6% | 18.7% | 15.0% | 11.3% | 1.9% | 14.4% | 13.0% | 1.3% | 19.4% |
| Current ratio | 7.98 | 8.84 | 4.65 | 9.06 | 11.18 | 12.96 | 10.06 | 9.50 | 8.61 | 9.25 |
| Revenue growth | 14.4% | 11.7% | 23.0% | 27.5% | 31.8% | -17.7% | 26.5% | 31.9% | -29.0% | 2.9% |
| EPS growth | 16.7% | 11.1% | 32.4% | 37.8% | 572.7% | -85.9% | 50.0% | 1,200.0% | -93.3% | 0.0% |